Adaptin Bio APTN
OTC APTN
$6.27 +0.02 (+0.32%)
At close: Aug 3, 2026 · 4:00 PM UTC

Adaptin Bio (APTN) Return on Assets (2024 - 2026)

Adaptin Bio (APTN) posted Return on Assets of 0.09% for Q1 2026, down 33.3% sequentially from 0.06% in Q4 2025, and down 6.0% YoY from 0.09% in Q1 2025.

Adaptin Bio (APTN) Return on Assets (2024 - 2026) Analysis & Trends

Adaptin Bio has reported Return on Assets for 3 years, with the latest figure at 0.09% in Q1 2026.

  • Quarterly Return on Assets fell 6.0% year-over-year to 0.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09% (down 6.0% YoY) and the FY2025 annual result came in at 0.1%, up 11.0% from the prior year.
  • Return on Assets fell to 0.09% in Q1 2026 per APTN's latest filing, from 0.06% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.02% in Q2 2025 and troughed at 72.53% in Q3 2024.
  • A 3-year average of 13.46% and a median of 0.09% in 2026 frame the typical range for Return on Assets.
  • The sharpest annual moves came in 2025 and 2026: Return on Assets surged 7249 bps in 2025, then dropped 6 bps in 2026.
  • Over 3 years, Return on Assets stood at 0.26% in 2024, then jumped by 75 bps to 0.06% in 2025, then slumped by 33 bps to 0.09% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods registered 0.09%, 0.06%, and 0.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.06%
Mar 31, 2026 -0.09%
Dec 31, 2025 -0.06%
Sep 30, 2025 -0.04%
Jun 30, 2025 -0.02%
Mar 31, 2025 -0.02%
Dec 31, 2024 -0.26%
Sep 30, 2024 -72.53%
Jun 30, 2024 -36.20%
Mar 31, 2024 -11.89%